CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 30, 2009--
Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m.
ET on Thursday, August 6, 2009, to discuss the company’s financial
results for the first quarter of fiscal 2010. Management will review the
quarter and provide an update on the company.
The conference call will be webcast on the investor relations section of
Alkermes’ website at www.alkermes.com
or may be accessed by dialing 1-866-814-8482 for domestic callers and
1-703-639-1372 for international callers. The conference call ID number
is 1383340.
A replay of the conference call will be available from 7:30 p.m. ET on
Thursday, August 6, 2009, through 5:00 p.m. ET on Thursday, August 13,
2009, and may be accessed by visiting Alkermes’ website or by dialing
1-888-266-2081 for domestic callers and 1-703-925-2533 for international
callers. The replay access code is 1383340.
About Alkermes
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia and bipolar I disorder. Alkermes' robust pipeline
includes extended-release injectable, pulmonary and oral products for
the treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Headquartered in Cambridge,
Massachusetts, Alkermes has research facilities in Massachusetts and a
commercial manufacturing facility in Ohio.
Source: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate
Communications
